Invesco’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $521K | Buy |
140,325
+22,557
| +19% | +$83.7K | ﹤0.01% | 3138 |
|
|
2025
Q1 | $380K | Buy |
117,768
+89,611
| +318% | +$289K | ﹤0.01% | 3253 |
|
|
2024
Q4 | $157K | Buy |
28,157
+732
| +3% | +$4.08K | ﹤0.01% | 3540 |
|
|
2024
Q3 | $296K | Sell |
27,425
-27
| -0.1% | -$292 | ﹤0.01% | 3404 |
|
|
2024
Q2 | $576K | Sell |
27,452
-217
| -0.8% | -$4.56K | ﹤0.01% | 3205 |
|
|
2024
Q1 | $882K | Buy |
27,669
+13,591
| +97% | +$433K | ﹤0.01% | 3044 |
|
|
2023
Q4 | $285K | Sell |
14,078
-3,398
| -19% | -$68.8K | ﹤0.01% | 3441 |
|
|
2023
Q3 | $222K | Sell |
17,476
-198,100
| -92% | -$2.52M | ﹤0.01% | 3537 |
|
|
2023
Q2 | $3.9M | Buy |
+215,576
| New | +$3.9M | ﹤0.01% | 2357 |
|
|
2023
Q1 | – | Sell |
-196,201
| Closed | -$4.36M | – | 3891 |
|
|
2022
Q4 | $4.36M | Buy |
196,201
+185,652
| +1,760% | +$4.12M | ﹤0.01% | 2314 |
|
|
2022
Q3 | $85K | Sell |
10,549
-104
| -1% | -$838 | ﹤0.01% | 3836 |
|
|
2022
Q2 | $75K | Sell |
10,653
-92
| -0.9% | -$648 | ﹤0.01% | 3904 |
|
|
2022
Q1 | $163K | Sell |
10,745
-235
| -2% | -$3.57K | ﹤0.01% | 3767 |
|
|
2021
Q4 | $241K | Buy |
+10,980
| New | +$241K | ﹤0.01% | 3672 |
|